Trials / Unknown
UnknownNCT01299753
Catecholamine Blockade Post-burn
Clinical and Molecular Effects of Catecholamine Blockade Post-burn
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Sunnybrook Health Sciences Centre · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
Severe burn is associated with a wide array of stress, metabolic, and physiologic processes in an attempt to restore homeostasis. The catecholamine induced stress response following severe burns is particularly exaggerated and manifests detrimentally as inflammation, insulin resistance, hypermetabolism, and associated profound protein catabolism. The investigators hypothesize that catecholamine blockade will lead to restored IR signaling and result in improved post-burn morbidity. The investigators will further determine the molecular mechanisms mediating these effects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | placebo | identically packed placebo |
| DRUG | propranolol | 20-40 mg q6-8h |
Timeline
- Start date
- 2011-02-01
- Primary completion
- 2022-12-31
- Completion
- 2023-12-31
- First posted
- 2011-02-18
- Last updated
- 2022-03-28
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT01299753. Inclusion in this directory is not an endorsement.